Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aptapharma is a specialized pharmaceutical company focused on the development and manufacturing of advanced drug delivery systems, particularly for oral, nasal, and pulmonary administration. The company provides comprehensive contract development and manufacturing services (CDMO), ranging from early-stage formulation and analytical testing to commercial-scale production. Aptapharma's expertise lies in creating complex dosage forms such as metered-dose inhalers, dry powder inhalers, and nasal sprays. By leveraging proprietary technologies, they aim to improve the bioavailability and patient compliance of both generic and branded therapeutic products. The company operates state-of-the-art facilities designed to meet global regulatory standards for high-quality pharmaceutical manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aptapharma.